Serotonin and depression: a disconnect between the advertisements and the scientific literature
- PMID: 16268734
- PMCID: PMC1277931
- DOI: 10.1371/journal.pmed.0020392
Serotonin and depression: a disconnect between the advertisements and the scientific literature
Abstract
Many ads for SSRI antidepressants claim that the drugs boost brain serotonin levels. Lacasse and Leo argue there is little scientific evidence to support this claim.
Conflict of interest statement
Figures
Comment in
-
Why did the FDA approve these advertisements?PLoS Med. 2006 Feb;3(2):e117; author reply e116. doi: 10.1371/journal.pmed.0030117. Epub 2006 Feb 28. PLoS Med. 2006. PMID: 16492081 Free PMC article. No abstract available.
-
Should industry speak the loudest in informing the public on medical matters?PLoS Med. 2006 Feb;3(2):e118; author reply e116. doi: 10.1371/journal.pmed.0030118. Epub 2006 Feb 28. PLoS Med. 2006. PMID: 16492082 Free PMC article. No abstract available.
-
Consumer advertising can be misleading.PLoS Med. 2006 Feb;3(2):e119; author reply e116. doi: 10.1371/journal.pmed.0030119. Epub 2006 Feb 28. PLoS Med. 2006. PMID: 16492083 Free PMC article. No abstract available.
-
Evident exception in clinical practice not sufficient to break traditional hypothesis.PLoS Med. 2006 Feb;3(2):e120; author reply e116. doi: 10.1371/journal.pmed.0030120. Epub 2006 Feb 28. PLoS Med. 2006. PMID: 16492084 Free PMC article. No abstract available.
Similar articles
-
Why did the FDA approve these advertisements?PLoS Med. 2006 Feb;3(2):e117; author reply e116. doi: 10.1371/journal.pmed.0030117. Epub 2006 Feb 28. PLoS Med. 2006. PMID: 16492081 Free PMC article. No abstract available.
-
Depression and serotonin: a never ending story.Curr Drug Targets. 2013 May 1;14(5):513. doi: 10.2174/1389450111314050001. Curr Drug Targets. 2013. PMID: 23547753 No abstract available.
-
Should industry speak the loudest in informing the public on medical matters?PLoS Med. 2006 Feb;3(2):e118; author reply e116. doi: 10.1371/journal.pmed.0030118. Epub 2006 Feb 28. PLoS Med. 2006. PMID: 16492082 Free PMC article. No abstract available.
-
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):709-10. doi: 10.1136/jnnp-2013-306829. Epub 2014 Jan 8. J Neurol Neurosurg Psychiatry. 2014. PMID: 24403283 Review. No abstract available.
-
Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.Cochrane Database Syst Rev. 2000;(4):CD002791. doi: 10.1002/14651858.CD002791. Cochrane Database Syst Rev. 2000. PMID: 11034764 Updated. Review.
Cited by
-
Is the mainstream construction of mood disorders resistant to systemic thinking?Front Psychiatry. 2024 Jan 19;14:1270027. doi: 10.3389/fpsyt.2023.1270027. eCollection 2023. Front Psychiatry. 2024. PMID: 38323024 Free PMC article.
-
Modeling vulnerability and intervention targets in the Borderline Personality Disorder system: A network analysis of in silico and in vivo interventions.PLoS One. 2023 Jul 31;18(7):e0289101. doi: 10.1371/journal.pone.0289101. eCollection 2023. PLoS One. 2023. PMID: 37523373 Free PMC article.
-
Selecting Antidepressants Based on Medical History and Stress Mechanism.Cureus. 2023 Apr 4;15(4):e37117. doi: 10.7759/cureus.37117. eCollection 2023 Apr. Cureus. 2023. PMID: 37168173 Free PMC article.
-
"Stabilise-reduce, stabilise-reduce": A survey of the common practices of deprescribing services and recommendations for future services.PLoS One. 2023 Mar 15;18(3):e0282988. doi: 10.1371/journal.pone.0282988. eCollection 2023. PLoS One. 2023. PMID: 36920968 Free PMC article.
-
Progressive and degenerative journals: on the growth and appraisal of knowledge in scholarly publishing.Eur J Philos Sci. 2022;12(4):61. doi: 10.1007/s13194-022-00492-8. Epub 2022 Nov 9. Eur J Philos Sci. 2022. PMID: 36407486 Free PMC article.
References
-
- International Marketing Services Health. Year-end U.S. Prescription and sales information and commentary. (Connecticut): Fairfield; 2004. International Marketing Services Health Available: http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_6989.... Accessed 14 October 2005.
-
- Donohue J, Berndt E. Effects of direct-to-consumer advertising on medication choice: The case of antidepressants. J Pub Pol Marketing. 2004;23:115–127.
-
- United Kingdom Parliament. House of Commons health report. London: United Kingdom House of Commons; 2005. Available: http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/4.... Accessed 14 October 2005.
-
- Pfizer. Zoloft advertisement. Burbank (California): NBC; 2004 March.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
